Author

L. M. Staudt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

D. w. Huang· 2 shared W. H. Wilson· 2 shared A. Bagaev· 1 shared A. J. Radtke· 1 shared A. L. Shaffer· 1 shared A. Mottok· 1 shared A. Telenius· 1 shared A. Varlamova· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. w. Huang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

A. J. Radtke, E. Postovalova, A. Varlamova, A. Bagaev, M. Sorokina, O. Kudryashova, M. Meerson, M. Polyakova, I. Galkin, V. Svekolkin, S. Isaev, G. Perelman, Y. Lozinsky, Z. Yaniv, B. C. Lowekamp, , R. N. Germain

This study creates a multi-scale, multiomic atlas of human normal and follicular lymphoma lymph nodes to identify tumor-specific features and microenvironmental patterns associated with early relapse.

bioRxiv · Jun 3, 2022Cancer Biology

Non-coding NFKBIZ 3' UTR mutations promote cell growth and resistance to targeted therapies in diffuse large B-cell lymphoma

S. E. Arthur, J. Gao, S. Healy, C. K. Rushton, N. Thomas, L. K. Hilton, K. Dreval, J. Tang, M. Alcaide, R. Cojocaru, A. Mottok, A. Telenius, P. Unrau, W. H. Wilson, L. M. Staudt, , R. D. Morin

This study identifies non-coding NFKBIZ 3' UTR mutations as drivers of DLBCL growth and resistance to NF-κB-targeted therapies, suggesting their potential as biomarkers.

bioRxiv · May 22, 2021 · PreprintCancer Biology

Genome-wide Screens Identify Lineage- and Tumor Specific-Genes Modulating MHC-I and MHC-II Immunosurveillance in Human Lymphomas

D. Dersh, J. D. Phelan, M. E. Gumina, B. Wang, J. H. Arbuckle, J. Holly, R. J. Kishton, T. E. Markowitz, M. O. Seedhom, N. Fridlyand, G. W. Wright, D. W. Huang, M. Ceribelli, C. J. Thomas, J. B. Lack, , J. W. Yewdell

The paper identifies genes modulating MHC-I and MHC-II expression in lymphomas, revealing potential targets for immunosurveillance manipulation.

bioRxiv · Mar 13, 2020Cancer Biology